Sign in

CIK 0001764013

  • Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
832771572
Phone
+1 917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$895,852
in 9 filings, $173K under 10b5-1 plans

Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-04-25 Macias William L. Chief Medical Officer Sale −509 $16.29 $8K 350,151
2023-04-25 Levine Mark S. Chief Legal Officer Sale −2,633 $16.29 $43K 330,691
2023-04-18 Barnett Eva Renee Chief Financial Officer Sale −3,423 $15.27 $52K 352,588
2023-04-18 Butchko Julia G. Chief Development Officer Sale −1,544 $15.27 $24K 430,063
2023-04-18 Salzmann Peter Chief Executive Officer Sale −3,395 $15.27 $52K 1,234,369
2023-04-17 Stout Jay S Chief Technology Officer Grant or award +100,000 100,000
2023-04-17 Stout Jay S Chief Technology Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2023-04-12 Pande Atul Director Grant or award +12,523 95,508
2023-04-12 Pande Atul Director Grant or award · Stock Option (right to buy) +16,260 16,260
2023-04-12 Hughes Douglas J. Director Grant or award +12,523 113,755
2023-04-12 Hughes Douglas J. Director Grant or award · Stock Option (right to buy) +16,260 16,260

Page 18 of 18 · 351 trades